Laļ, J L <br/><br/>
Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.  [electronic resource] 

 -  Blood  May 1995 
 - 2490-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aneuploidy<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Bone Marrow--drug effects<br/>C-Reactive Protein--analysis<br/>Chromosome Aberrations<br/>Chromosomes, Human--ultrastructure<br/>Female<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Humans<br/>Interleukin-3--pharmacology<br/>Interleukin-6--pharmacology<br/>Karyotyping--methods<br/>Ki-67 Antigen<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Multivariate Analysis<br/>Myeloma Proteins--analysis<br/>Neoplasm Proteins--blood<br/>Nuclear Proteins--blood<br/>Prognosis<br/>Proportional Hazards Models<br/>Risk Factors<br/>Survival Analysis<br/>Treatment Failure<br/>Tumor Cells, Cultured--drug effects<br/>beta 2-Microglobulin--analysis